SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it will present at the LD MICRO Conference on Thursday, December 3, 2009 at 2:00 p.m. (PST) at the Luxe Hotel in Los Angeles. Aethlon Medical's Chairman and CEO, James A. Joyce, will present a corporate overview and will provide an update on the company's clinical progress for its lead product, the Hemopurifier®, a first-in-class artificial adjunct to the immune system proven to capture infectious viruses and immunosuppressive particles from the human circulatory system.
The LD MICRO Conference brings together 75 presenting companies with over 100 institutions focused on investing in small and micro cap companies across a breadth of industries.
About Aethlon Medical
Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.
About LD MICRO
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.
For more information on the list of presenting companies or to register for the event, please visit http://www.ldmicro.com or call (408) 457-1042
Contact: At the Company: Jim Frakes Senior VP Finance 858.459.7800 x300 firstname.lastname@example.org or Jim Joyce Chairman, CEO 858.459.7800 x301 email@example.com Investor Relations: RedChip Companies, Inc. Jon Cunningham (800) 733-2447, Ext. 107 firstname.lastname@example.org
SOURCE Aethlon Medical, Inc.
|SOURCE Aethlon Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved